Improvements of cardiac electrophysiologic stability and ventricular fibrillation threshold in rats with myocardial infarction treated with cardiac stem cells

Critical Care Medicine

Volumn 39, Issue 5, 2011, Pages 1082-1088

  Zheng, Shaoxin ^a   Zhou, Changqing ^a   Weng, Yinlun ^a,b   Huang, Hui ^a   Wu, Hao ^c   Huang, Jing ^c   Wu, Wei ^a   Sun, Shijie ^b   Wang, Jingfeng ^a   Tang, Wanchun ^a,b   Wang, Tong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b INSTITUTE OF CRITICAL CARE MEDICINE   (United States)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

arrhythmia; cardiac stem cells; electrophysiologic characteristics; myocardial infarction; ventricular fibrillation threshold

Indexed keywords

ALPHA ACTIN; ALPHA SARCOMERIC ACTIN; ALPHA SMOOTH MUSCLE ACTIN; CONNEXIN 43; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CARDIAC STEM CELL; CELL LABELING; CONFERENCE PAPER; CONTROLLED STUDY; DISPERSION; ELECTROGRAPHY; FROZEN SECTION; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE WALL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT; SPRAGUE DAWLEY RAT; STEM CELL; STEM CELL TRANSPLANTATION;

EID: 79955367836     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318206d6e8     Document Type: Conference Paper

References (38)

1. Herrmann JL, Abarbanell AM, Weil BR, et al: Cell-based therapy for ischemic heart dis-ease: A clinical update. Ann Thorac Surg 2009; 88:1714-1722
2. LaPar DJ, Kron IL, Yang Z: Stem cell therapy for ischemic heart disease: Where are we? Curr Opin Organ Transplant 2009; 14:79-84
3. Menasché P: [Cell therapy: results in cardi-ology]. Bull Acad Natl Med 2009; 193: 559-568; discussion 568-569
4. Schächinger V, Erbs S, Elsässer A, et al: Intracoronary bone marrow-derived progen-itor cells in acute myocardial infarction. NEngl JMed 2006; 355:1210-1221 (Pubitemid 44427445)
5. Beltrami AP, Barlucchi L, Torella D, et al: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763-776 (Pubitemid 37186770)
6. Bearzi C, Rota M, Hosoda T, et al: Human cardiac stem cells. Proc Natl Acad Sci USA 2007; 104:14068-14073 (Pubitemid 350003336)
7. Lu DF, Wu H, Huang J, et al: [Isolation, in vitro culture and identification of cardiac stem cells from neonatal SD rats]. Nan Fang Yi Ke Da Xue Xue Bao 2006; 26:1629-1632
8. Kajstura J, Urbanek K, Rota M, et al: Cardiac stem cells and myocardial disease. J Mol Cell Cardiol 2008; 45:505-513
9. Leri A, Kajstura J, Anversa P: Cardiac stem cells and mechanisms of myocardial regen-eration. Physiol Rev 2005; 85:1373-1416 (Pubitemid 41362274)
10. Dawn B, Stein AB, Urbanek K, et al: Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myo-cardium, and improve cardiac function. Proc Natl Acad Sci USA 2005; 102:3766-3771 (Pubitemid 40354686)
11. Smith RR, Barile L, Cho HC, et al: Regener-ative potential of cardiosphere-derived cells expanded from percutaneous endomyocar-dial biopsy specimens. Circulation 2007; 115: 896-908 (Pubitemid 46294730)
12. Tang XL, Rokosh G, Sanganalmath SK, et al: Intracoronary administration of cardiac pro-genitor cells alleviates left ventricular dys-function in rats with a 30-day-old infarction. Circulation 2010; 121:293-305
13. Padin-Iruegas ME, Misao Y, Davis ME, et al: Cardiac progenitor cells and biotinylated in-sulin-like growth factor-1 nanofibers im-prove endogenous and exogenous myocardial regeneration after infarction. Circulation 2009; 120:876-887
14. Camporesi S, Bortolotti L: Reproductive cloning in humans and therapeutic cloning in primates: Is the ethical debate catching up with the recent scientific advances? J Med Ethics 2008; 34:e15
15. Oettgen P: Cardiac stem cell therapy: Need for optimization of efficacy and safety moni-toring. Circulation 2006; 14:353-358 (Pubitemid 44297101)
16. Chamuleau SA, Vrijsen KR, Rokosh DG, et al: Cell therapy for ischaemic heart disease: Fo-cus on the role of resident cardiac stem cells. Neth Heart J 2009; 17:199-207
17. Menasché P: Stem cell therapy for heart fail-ure: Are arrhythmias a real safety concern? Circulation 2009; 119:2735-2740
18. Ly HQ, Nattel S: Stem cells are not proar-rhythmic: letting the genie out of the bottle. Circulation 2009; 119:1824-1831
19. Gepstein L: Electrophysiologic implications of myocardial stem cell therapies. Heart Rhythm 2008; 5:S48-S52
20. Wang T, Tang W, Sun S, et al: Intravenous infusion of bone marrow mesenchymal stem cells improves myocardial function in a rat model of myocardial ischemia. Crit Care Med 2007; 35:2587-2593 (Pubitemid 351339021)
21. Wang T, Tang W, Sun S, et al: Mesenchymal stem cells improve outcomes of cardiopul-monary resuscitation in myocardial infarcted rats. J Mol Cell Cardiol 2009; 46:378-384
22. Wang T, Tang W, Sun S, et al: Intravenous infusion of bone marrow mesenchymal stem cells improves brain function after resuscita-tion from cardiac arrest. Crit Care Med 2008; 36:S486-S491
23. Xia Y, Kongstad O, Hertervig E, et al: Acti-vation recovery time measurements in eval-uation of global sequence and dispersion of ventricular repolarization. J Electrocardiol 2005; 38:28-35 (Pubitemid 40127173)
24. Wang H, Tang W, Ristagno G, et al: The potential mechanisms of reduced incidence of ventricular fibrillation as the presenting rhythm in sudden cardiac arrest. Crit Care Med 2009; 37:26-31
25. Boyle AJ, Schulman SP, Hare JM, et al: Is stem cell therapy ready for patients? Stem Cell Ther-apy for Cardiac Repair. Ready for the Next Step. Circulation 2006; 114:339-352 (Pubitemid 44297100)
26. Makkar RR, Lill M, Chen PS: Stem cell therapy for myocardial repair: Is it arrhythmogenic? J Am Coll Cardiol 2003; 42:2070-2072 (Pubitemid 37549886)
27. Zhang YM, Hartzell C, Narlow M, et al: Stem cell-derived cardiomyocytes demonstrate ar-rhythmic potential. Circulation 2002; 106: 1294-1299 (Pubitemid 34988651)
28. Rota M, Padin-Iruegas ME, Misao Y, et al: Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 2008; 103:107-116
29. Akar FG, Rosenbaum DS: Transmural elec-trophysiological heterogeneities underlying arrhythmogenesis in heart failure. Circ Res 2003; 93:638-645 (Pubitemid 37222160)
30. Obreztchikova MN, Sosunov EA, Anyuk-hovsky EP, et al: Heterogeneous ventricular repolarization provides a substrate for ar-rhythmias in a German shepherd model of spontaneous arrhythmic death. Circulation 2003; 108:1389-1394 (Pubitemid 37174419)
31. Sun Y: Myocardial repair/remodelling follow-ing infarction: Roles of local factors. Cardio-vasc Res 2009; 81:482-490
32. Sharma R, Raghubir R: Stem cell therapy: A hope for dying hearts. Stem Cells Dev 2007; 16:517-536 (Pubitemid 47378726)
33. de Boer TP, van Veen TA, Jonsson MK, et al: Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype. J Mol Cell Cardiol 2010; 48:254-260
34. Wang D, Shen W, Zhang F, et al: Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart. Cell Biol Int 2010; 34: 415-423
35. van Rijen HV, Eckardt D, Degen J, et al: Slow conduction and enhanced anisotropy in-crease the propensity for ventricular tachy-arrhythmias in adult mice with induced de-letion ofconnexin43. Circulation 2004; 109: 1048-1055 (Pubitemid 38282860)
36. Fernandes S, Amirault JC, Lande G, et al: Autologous myoblast transplantation after myocardial infarction increases the induc-ibility ofventricular arrhythmias. Cardiovasc Res 2006; 69:348-358 (Pubitemid 43098791)
37. Abraham MR, Henrikson CA, Tung L, et al: Antiarrhythmic engineering of skeletal myo-blasts for cardiac transplantation. Circ Res 2005; 97:159-167 (Pubitemid 41033472)
38. Wang D, Zhang F, Shen W, et al: Mesenchy-mal stem cell injection ameliorates the in-ducibility of ventricular arrhythmias after myocardial infarction in rats. Int J Cardiol 2010 Jul 30. [Epub ahead ofprint]